Watson Rebecca’s Guardant Health GH Stock Holding History

Watson Rebecca’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-700	Closed	-$57K	–	189
2020 Q2	$57K	Buy	+700	New	+$56.4K	0.03%	149

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Watson Rebecca's GH Position: Q3 2020 in Review

Watson Rebecca sold out of Guardant Health (GH) in Q3 2020, closing a stake of 700 shares — an estimated $57K sold.

Watson Rebecca first reported a position in GH in Q2 2020 and held it in 1 quarter. The position peaked at $57K in Q2 2020. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

Watson Rebecca reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
Watson Rebecca sold 700 Guardant Health shares in Q3 2020, an estimated $57K.
Watson Rebecca first reported a position in Guardant Health in Q2 2020 and held it in 1 quarter.
Watson Rebecca's Guardant Health position peaked at $57K in Q2 2020.
346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.